Use of CAM by Hospice Oncology Patients During Ambulatory Palliative Care (CAM)

November 15, 2018 updated by: Łukasz Pietrzyński, Silesian University of Medicine

Use of Complementary and Alternative Medicine by Hospice Oncology Patients During Ambulatory Palliative Care

The aim of the study is to assess Prevalence of complementary and alternative therapy use by adult patients from the area of Silesian agglomeration (Poland) with advanced, metastatic cancer disease who were admitted to "Pro Salute" Hospice for ambulatory palliative care between July 2017 and September 2018

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The research team developed the CAT (complementary and alternative therapy) screening tool to obtain information about CAM use from patients. The screening tool was based on a The National Center for Complementary and Alternative Medicine's (NCCAM) classification of CAM. CAT were grouped into five main categories: (1) biologically based therapies , (2) mind/body therapies, (3) manipulative and body-based therapies, (4) Energy therapies and (5) alternative medical systems.

The questionaire was tailored to meet the objectives of this study and to be adjusted to hospice patients specifics. It was piloted on the group of 25 patients, resulting in some vocabulary changes. The final questionnaire consists of 25 multiple-choice, semi-structured questions and takes about 15 min to complete. For each general CAM category the detailed information was collected on the type of specific therapy that was used. Patients were considered as CAM users if they have used at least one therapy from at least one of the categories during the period of 12 months prior to the screening. Patients were asked to specify the reasons for CAT usage, experienced effects of the therapy, stage at which patients considered using CAM

Study Type

Observational

Enrollment (Actual)

1004

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Poland
      • Będzin, Poland, 42-500
        • PZZOZ Będzin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

adult patients from the area of Silesian agglomeration (Poland) with advanced, metastatic cancer disease who were admitted to "Pro Salute" Hospice for ambulatory palliative care between July 2017 and September 2018

Description

Inclusion Criteria:

  • adult patients from the area of Silesian agglomeration (Poland) with advanced, metastatic cancer disease who were admitted to "Pro Salute" Hospice for ambulatory palliative care between July 2017 and September 2018

Exclusion Criteria:

  • Patients were excluded from the survey if they presented cognitive disturbances disabling credible answers in the questionnaire

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Variation of prevalence of complementary and alternative therapy use by hospice patients
Time Frame: 14 months
Presence and quantity of patients using any CAM therapies -The research team developed the CAT screening tool based on a The National Center for Complementary and Alternative Medicine's (NCCAM) classification of CAM. Questionnaire consists of 25 multiple-choice, semi-structured questions and gives the result in the form of a percentage
14 months
Variation of prevalence of biologically based therapies
Time Frame: 14 months
Presence and quantity of patients using biologically based therapies - The research team developed the CAT screening tool based on a The National Center for Complementary and Alternative Medicine's (NCCAM) classification of CAM. Questionnaire consists of 25 multiple-choice, semi-structured questions and gives the result in the form of a percentage
14 months
Variation of prevalence of mind/body therapies
Time Frame: 14 months
Presence and quantity of patients using mind/body therapies - The research team developed the CAT screening tool based on a The National Center for Complementary and Alternative Medicine's (NCCAM) classification of CAM. Questionnaire consists of 25 multiple-choice, semi-structured questions and gives the result in the form of a percentage
14 months
Variation of prevalence of manipulative and body-based therapies
Time Frame: 14 months
Presence and quantity of patients using manipulative and body-based therapies - The research team developed the CAT screening tool based on a The National Center for Complementary and Alternative Medicine's (NCCAM) classification of CAM. Questionnaire consists of 25 multiple-choice, semi-structured questions and gives the result in the form of a percentage
14 months
Variation of prevalence of biologically Energy therapies
Time Frame: 14 months
Presence and quantity of patients using Energy therapies - The research team developed the CAT screening tool based on a The National Center for Complementary and Alternative Medicine's (NCCAM) classification of CAM. Questionnaire consists of 25 multiple-choice, semi-structured questions and gives the result in the form of a percentage
14 months
Variation of prevalence of alternative medical systems
Time Frame: 14 months
Presence and quantity of patients using alternative medical systems - The research team developed the CAT screening tool based on a The National Center for Complementary and Alternative Medicine's (NCCAM) classification of CAM. Questionnaire consists of 25 multiple-choice, semi-structured questions and gives the result in the form of a percentage
14 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Silesian University of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 12, 2018

Primary Completion (Actual)

September 12, 2018

Study Completion (Actual)

September 12, 2018

Study Registration Dates

First Submitted

October 23, 2018

First Submitted That Met QC Criteria

November 15, 2018

First Posted (Actual)

November 20, 2018

Study Record Updates

Last Update Posted (Actual)

November 20, 2018

Last Update Submitted That Met QC Criteria

November 15, 2018

Last Verified

November 1, 2018

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • CAM001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hospice Care

Clinical Trials on complementary and alternative therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe